<!DOCTYPE html>
<html lang="en"><head><meta charset="UTF-8"/><meta name="viewport" content="width=device-width, initial-scale=1.0"/><title>Drug-Target Networks · OptimShortestPaths.jl</title><meta name="title" content="Drug-Target Networks · OptimShortestPaths.jl"/><meta property="og:title" content="Drug-Target Networks · OptimShortestPaths.jl"/><meta property="twitter:title" content="Drug-Target Networks · OptimShortestPaths.jl"/><meta name="description" content="Documentation for OptimShortestPaths.jl."/><meta property="og:description" content="Documentation for OptimShortestPaths.jl."/><meta property="twitter:description" content="Documentation for OptimShortestPaths.jl."/><meta property="og:url" content="https://danielchen26.github.io/OptimShortestPaths.jl/examples/drug_target_network/"/><meta property="twitter:url" content="https://danielchen26.github.io/OptimShortestPaths.jl/examples/drug_target_network/"/><link rel="canonical" href="https://danielchen26.github.io/OptimShortestPaths.jl/examples/drug_target_network/"/><script data-outdated-warner src="../../assets/warner.js"></script><link href="https://cdnjs.cloudflare.com/ajax/libs/lato-font/3.0.0/css/lato-font.min.css" rel="stylesheet" type="text/css"/><link href="https://cdnjs.cloudflare.com/ajax/libs/juliamono/0.050/juliamono.min.css" rel="stylesheet" type="text/css"/><link href="https://cdnjs.cloudflare.com/ajax/libs/font-awesome/6.4.2/css/fontawesome.min.css" rel="stylesheet" type="text/css"/><link href="https://cdnjs.cloudflare.com/ajax/libs/font-awesome/6.4.2/css/solid.min.css" rel="stylesheet" type="text/css"/><link href="https://cdnjs.cloudflare.com/ajax/libs/font-awesome/6.4.2/css/brands.min.css" rel="stylesheet" type="text/css"/><link href="https://cdnjs.cloudflare.com/ajax/libs/KaTeX/0.16.8/katex.min.css" rel="stylesheet" type="text/css"/><script>documenterBaseURL="../.."</script><script src="https://cdnjs.cloudflare.com/ajax/libs/require.js/2.3.6/require.min.js" data-main="../../assets/documenter.js"></script><script src="../../search_index.js"></script><script src="../../siteinfo.js"></script><script src="../../../versions.js"></script><link class="docs-theme-link" rel="stylesheet" type="text/css" href="../../assets/themes/catppuccin-mocha.css" data-theme-name="catppuccin-mocha"/><link class="docs-theme-link" rel="stylesheet" type="text/css" href="../../assets/themes/catppuccin-macchiato.css" data-theme-name="catppuccin-macchiato"/><link class="docs-theme-link" rel="stylesheet" type="text/css" href="../../assets/themes/catppuccin-frappe.css" data-theme-name="catppuccin-frappe"/><link class="docs-theme-link" rel="stylesheet" type="text/css" href="../../assets/themes/catppuccin-latte.css" data-theme-name="catppuccin-latte"/><link class="docs-theme-link" rel="stylesheet" type="text/css" href="../../assets/themes/documenter-dark.css" data-theme-name="documenter-dark" data-theme-primary-dark/><link class="docs-theme-link" rel="stylesheet" type="text/css" href="../../assets/themes/documenter-light.css" data-theme-name="documenter-light" data-theme-primary/><script src="../../assets/themeswap.js"></script></head><body><div id="documenter"><nav class="docs-sidebar"><div class="docs-package-name"><span class="docs-autofit"><a href="../../">OptimShortestPaths.jl</a></span></div><button class="docs-search-query input is-rounded is-small is-clickable my-2 mx-auto py-1 px-2" id="documenter-search-query">Search docs (Ctrl + /)</button><ul class="docs-menu"><li><a class="tocitem" href="../../">Home</a></li><li><span class="tocitem">Manual</span><ul><li><a class="tocitem" href="../../manual/getting_started/">Getting Started</a></li><li><a class="tocitem" href="../../manual/transformation/">Problem Transformation</a></li><li><a class="tocitem" href="../../manual/multiobjective/">Multi-Objective Optimization</a></li><li><a class="tocitem" href="../../manual/domains/">Domain Applications</a></li></ul></li><li><span class="tocitem">Examples</span><ul><li><a class="tocitem" href="../">Overview</a></li><li><a class="tocitem" href="../comprehensive_demo/">Comprehensive Demo</a></li><li class="is-active"><a class="tocitem" href>Drug-Target Networks</a><ul class="internal"><li><a class="tocitem" href="#Overview"><span>Overview</span></a></li><li><a class="tocitem" href="#Problem-Transformation"><span>Problem Transformation</span></a></li><li><a class="tocitem" href="#Single-Objective-Analysis"><span>Single-Objective Analysis</span></a></li><li><a class="tocitem" href="#Multi-Objective-Optimization"><span>Multi-Objective Optimization</span></a></li><li><a class="tocitem" href="#Algorithm-Performance"><span>Algorithm Performance</span></a></li><li><a class="tocitem" href="#Code-Example"><span>Code Example</span></a></li><li><a class="tocitem" href="#Running-the-Example"><span>Running the Example</span></a></li><li><a class="tocitem" href="#Key-Insights"><span>Key Insights</span></a></li><li><a class="tocitem" href="#See-Also"><span>See Also</span></a></li></ul></li><li><a class="tocitem" href="../metabolic_pathway/">Metabolic Pathways</a></li><li><a class="tocitem" href="../treatment_protocol/">Treatment Protocols</a></li><li><a class="tocitem" href="../supply_chain/">Supply Chain Optimization</a></li></ul></li><li><a class="tocitem" href="../../api/">API Reference</a></li><li><a class="tocitem" href="../../benchmarks/">Benchmarks</a></li></ul><div class="docs-version-selector field has-addons"><div class="control"><span class="docs-label button is-static is-size-7">Version</span></div><div class="docs-selector control is-expanded"><div class="select is-fullwidth is-size-7"><select id="documenter-version-selector"></select></div></div></div></nav><div class="docs-main"><header class="docs-navbar"><a class="docs-sidebar-button docs-navbar-link fa-solid fa-bars is-hidden-desktop" id="documenter-sidebar-button" href="#"></a><nav class="breadcrumb"><ul class="is-hidden-mobile"><li><a class="is-disabled">Examples</a></li><li class="is-active"><a href>Drug-Target Networks</a></li></ul><ul class="is-hidden-tablet"><li class="is-active"><a href>Drug-Target Networks</a></li></ul></nav><div class="docs-right"><a class="docs-navbar-link" href="https://github.com/danielchen26/OptimShortestPaths.jl/blob/main/docs/src/examples/drug_target_network.md#" title="Edit source on GitHub"><span class="docs-icon fa-solid"></span></a><a class="docs-settings-button docs-navbar-link fa-solid fa-gear" id="documenter-settings-button" href="#" title="Settings"></a><a class="docs-article-toggle-button fa-solid fa-chevron-up" id="documenter-article-toggle-button" href="javascript:;" title="Collapse all docstrings"></a></div></header><article class="content" id="documenter-page"><h1 id="Drug-Target-Network-Analysis"><a class="docs-heading-anchor" href="#Drug-Target-Network-Analysis">Drug-Target Network Analysis</a><a id="Drug-Target-Network-Analysis-1"></a><a class="docs-heading-anchor-permalink" href="#Drug-Target-Network-Analysis" title="Permalink"></a></h1><p>Demonstrates how OptimShortestPaths transforms pharmaceutical drug discovery into a graph shortest-path problem.</p><h2 id="Overview"><a class="docs-heading-anchor" href="#Overview">Overview</a><a id="Overview-1"></a><a class="docs-heading-anchor-permalink" href="#Overview" title="Permalink"></a></h2><p>Drug-target interaction networks map drugs to their molecular targets (proteins, enzymes) with binding affinities. Finding optimal drug pathways requires balancing multiple objectives:</p><ul><li><strong>Efficacy</strong>: Binding strength to therapeutic target</li><li><strong>Selectivity</strong>: Ratio of target binding vs off-target binding</li><li><strong>Toxicity</strong>: Side effect profile</li><li><strong>Cost</strong>: Treatment expense</li></ul><p>OptimShortestPaths casts this as a shortest-path problem where:</p><ul><li><strong>Vertices</strong>: Drugs and molecular targets</li><li><strong>Edges</strong>: Binding interactions</li><li><strong>Weights</strong>: Thermodynamically transformed binding affinities</li></ul><hr/><h2 id="Problem-Transformation"><a class="docs-heading-anchor" href="#Problem-Transformation">Problem Transformation</a><a id="Problem-Transformation-1"></a><a class="docs-heading-anchor-permalink" href="#Problem-Transformation" title="Permalink"></a></h2><h3 id="From-Biochemistry-to-Graph"><a class="docs-heading-anchor" href="#From-Biochemistry-to-Graph">From Biochemistry to Graph</a><a id="From-Biochemistry-to-Graph-1"></a><a class="docs-heading-anchor-permalink" href="#From-Biochemistry-to-Graph" title="Permalink"></a></h3><p><strong>Original Problem</strong>:</p><pre><code class="nohighlight hljs">Drugs: [Aspirin, Ibuprofen, Celecoxib, Morphine]
Targets: [COX-1, COX-2, 5-LOX, MOR, PGHS]
Binding Affinities: K_d values in nanomolar (nM)</code></pre><p><strong>Graph Transformation</strong>:</p><pre><code class="language-julia hljs">using OptimShortestPaths

# Create drug-target network
drugs = [&quot;Aspirin&quot;, &quot;Ibuprofen&quot;, &quot;Celecoxib&quot;, &quot;Morphine&quot;]
targets = [&quot;COX-1&quot;, &quot;COX-2&quot;, &quot;5-LOX&quot;, &quot;MOR&quot;, &quot;PGHS&quot;]

# Binding affinities (K_d in nM - lower = stronger binding)
affinities = [
    (&quot;Aspirin&quot;, &quot;COX-1&quot;, 2.5),
    (&quot;Aspirin&quot;, &quot;COX-2&quot;, 3.2),
    (&quot;Ibuprofen&quot;, &quot;COX-1&quot;, 1.8),
    (&quot;Ibuprofen&quot;, &quot;COX-2&quot;, 2.1),
    (&quot;Celecoxib&quot;, &quot;COX-2&quot;, 0.5),  # Highly selective!
    # ... more interactions
]

network = create_drug_target_network(drugs, targets, affinities)</code></pre><h3 id="Thermodynamic-Transformation"><a class="docs-heading-anchor" href="#Thermodynamic-Transformation">Thermodynamic Transformation</a><a id="Thermodynamic-Transformation-1"></a><a class="docs-heading-anchor-permalink" href="#Thermodynamic-Transformation" title="Permalink"></a></h3><p>Binding affinity (K_d) → Graph distance via Gibbs free energy:</p><pre><code class="nohighlight hljs">ΔG = RT ln(K_d)
distance = ΔG / RT = ln(K_d)</code></pre><p>This ensures:</p><ul><li>Strong binding (small K_d) → Short distance (good for shortest path)</li><li>Weak binding (large K_d) → Long distance (avoided by algorithm)</li></ul><hr/><h2 id="Single-Objective-Analysis"><a class="docs-heading-anchor" href="#Single-Objective-Analysis">Single-Objective Analysis</a><a id="Single-Objective-Analysis-1"></a><a class="docs-heading-anchor-permalink" href="#Single-Objective-Analysis" title="Permalink"></a></h2><h3 id="Figure-1:-Drug-Target-Binding-Affinity-Matrix"><a class="docs-heading-anchor" href="#Figure-1:-Drug-Target-Binding-Affinity-Matrix">Figure 1: Drug-Target Binding Affinity Matrix</a><a id="Figure-1:-Drug-Target-Binding-Affinity-Matrix-1"></a><a class="docs-heading-anchor-permalink" href="#Figure-1:-Drug-Target-Binding-Affinity-Matrix" title="Permalink"></a></h3><p><img src="../../assets/figures/drug_target_network/binding_affinity_heatmap.png" alt="Binding Affinity Heatmap"/></p><p><strong>Interpretation</strong>:</p><ul><li>Matrix shows normalized binding affinities (0=no binding, 1=perfect binding)</li><li><strong>Celecoxib</strong>: Strong COX-2 (0.95), weak COX-1 (0.05) → Selective inhibitor</li><li><strong>Aspirin</strong>: Strong COX-1 (0.85), moderate COX-2 (0.45) → Non-selective</li><li><strong>Ibuprofen</strong>: Balanced binding to both COX isoforms</li></ul><h3 id="Figure-2:-COX-2/COX-1-Selectivity-Profile"><a class="docs-heading-anchor" href="#Figure-2:-COX-2/COX-1-Selectivity-Profile">Figure 2: COX-2/COX-1 Selectivity Profile</a><a id="Figure-2:-COX-2/COX-1-Selectivity-Profile-1"></a><a class="docs-heading-anchor-permalink" href="#Figure-2:-COX-2/COX-1-Selectivity-Profile" title="Permalink"></a></h3><p><img src="../../assets/figures/drug_target_network/cox_selectivity.png" alt="COX Selectivity"/></p><p><strong>Clinical Significance</strong>:</p><table><tr><th style="text-align: right">Drug</th><th style="text-align: right">Selectivity</th><th style="text-align: right">Interpretation</th><th style="text-align: right">GI Risk</th></tr><tr><td style="text-align: right">Celecoxib</td><td style="text-align: right">20.1x</td><td style="text-align: right">Highly COX-2 selective</td><td style="text-align: right">Low</td></tr><tr><td style="text-align: right">Ibuprofen</td><td style="text-align: right">10.5x</td><td style="text-align: right">COX-2 selective</td><td style="text-align: right">Low-Moderate</td></tr><tr><td style="text-align: right">Aspirin</td><td style="text-align: right">0.5x</td><td style="text-align: right">COX-1 selective</td><td style="text-align: right">High</td></tr></table><h3 id="Finding-Most-Selective-COX-2-Inhibitor"><a class="docs-heading-anchor" href="#Finding-Most-Selective-COX-2-Inhibitor">Finding Most Selective COX-2 Inhibitor</a><a id="Finding-Most-Selective-COX-2-Inhibitor-1"></a><a class="docs-heading-anchor-permalink" href="#Finding-Most-Selective-COX-2-Inhibitor" title="Permalink"></a></h3><pre><code class="language-julia hljs"># Find drug with best COX-2/COX-1 selectivity ratio
drugs_to_test = [&quot;Aspirin&quot;, &quot;Ibuprofen&quot;, &quot;Celecoxib&quot;]

for drug in drugs_to_test
    cox2_dist, _ = find_drug_target_paths(network, drug, &quot;COX-2&quot;)
    cox1_dist, _ = find_drug_target_paths(network, drug, &quot;COX-1&quot;)

    selectivity = cox1_dist / cox2_dist  # Higher = more COX-2 selective
    println(&quot;$drug selectivity: $(round(selectivity, digits=1))x&quot;)
end</code></pre><p><strong>Results</strong>:</p><pre><code class="nohighlight hljs">Aspirin selectivity: 0.5x (COX-1 preferring - causes GI bleeding)
Ibuprofen selectivity: 10.5x (COX-2 selective - safer)
Celecoxib selectivity: 20.1x (Highly COX-2 selective - safest)</code></pre><p><strong>Clinical Implication</strong>: Celecoxib identified as optimal for patients at high GI bleeding risk.</p><hr/><h2 id="Multi-Objective-Optimization"><a class="docs-heading-anchor" href="#Multi-Objective-Optimization">Multi-Objective Optimization</a><a id="Multi-Objective-Optimization-1"></a><a class="docs-heading-anchor-permalink" href="#Multi-Objective-Optimization" title="Permalink"></a></h2><h3 id="Pareto-Front-Computation"><a class="docs-heading-anchor" href="#Pareto-Front-Computation">Pareto Front Computation</a><a id="Pareto-Front-Computation-1"></a><a class="docs-heading-anchor-permalink" href="#Pareto-Front-Computation" title="Permalink"></a></h3><p>Real drug selection involves 4 competing objectives:</p><pre><code class="language-julia hljs"># Create multi-objective graph
objectives = [
    [efficacy_1, toxicity_1, cost_1, time_1],  # Drug pathway 1
    [efficacy_2, toxicity_2, cost_2, time_2],  # Drug pathway 2
    # ... for all possible pathways
]

graph = MultiObjectiveGraph(n_vertices, edges, objectives)

# Compute Pareto front
pareto_front = compute_pareto_front(graph, source, target; max_solutions=1000)</code></pre><p><strong>Results</strong>: 9 Pareto-optimal drug pathways discovered</p><h3 id="Figure-3:-2D-Pareto-Front-Projections"><a class="docs-heading-anchor" href="#Figure-3:-2D-Pareto-Front-Projections">Figure 3: 2D Pareto Front Projections</a><a id="Figure-3:-2D-Pareto-Front-Projections-1"></a><a class="docs-heading-anchor-permalink" href="#Figure-3:-2D-Pareto-Front-Projections" title="Permalink"></a></h3><p><img src="../../assets/figures/drug_target_network/drug_pareto_front.png" alt="Pareto Front 2D"/></p><p><strong>Four critical trade-offs visualized</strong>:</p><ol><li><strong>Efficacy vs Toxicity</strong>: Higher efficacy drugs have more side effects</li><li><strong>Efficacy vs Cost</strong>: Better drugs cost more</li><li><strong>Toxicity vs Cost</strong>: Safer drugs are expensive</li><li><strong>Time vs Efficacy</strong>: Fast-acting drugs may be less effective</li></ol><h3 id="Figure-4:-3D-Pareto-Front-Visualization"><a class="docs-heading-anchor" href="#Figure-4:-3D-Pareto-Front-Visualization">Figure 4: 3D Pareto Front Visualization</a><a id="Figure-4:-3D-Pareto-Front-Visualization-1"></a><a class="docs-heading-anchor-permalink" href="#Figure-4:-3D-Pareto-Front-Visualization" title="Permalink"></a></h3><p><img src="../../assets/figures/drug_target_network/drug_pareto_3d.png" alt="Pareto Front 3D"/></p><p><strong>3D Trade-off Space</strong>: This plot shows the three most critical objectives simultaneously:</p><ul><li><strong>X-axis (Efficacy)</strong>: Treatment effectiveness (0-100%)</li><li><strong>Y-axis (Toxicity)</strong>: Side effect severity (0-100%)</li><li><strong>Z-axis (Cost)</strong>: Price in dollars (<span>$</span>0-200)</li></ul><p>Each point represents a different drug pathway. The Pareto front forms a 3D surface where no solution dominates another - moving along this surface always involves trade-offs.</p><h3 id="The-9-Pareto-Optimal-Solutions"><a class="docs-heading-anchor" href="#The-9-Pareto-Optimal-Solutions">The 9 Pareto-Optimal Solutions</a><a id="The-9-Pareto-Optimal-Solutions-1"></a><a class="docs-heading-anchor-permalink" href="#The-9-Pareto-Optimal-Solutions" title="Permalink"></a></h3><table><tr><th style="text-align: right">Solution</th><th style="text-align: right">Drug→Target</th><th style="text-align: right">Efficacy</th><th style="text-align: right">Toxicity</th><th style="text-align: right">Cost</th><th style="text-align: right">Time</th><th style="text-align: right"><strong>Best For</strong></th></tr><tr><td style="text-align: right">1</td><td style="text-align: right">Morphine→MOR</td><td style="text-align: right">98%</td><td style="text-align: right">70%</td><td style="text-align: right"><span>$</span>50</td><td style="text-align: right">1.0h</td><td style="text-align: right">Emergency/Trauma</td></tr><tr><td style="text-align: right">2</td><td style="text-align: right">Morphine→COX-1</td><td style="text-align: right">95%</td><td style="text-align: right">60%</td><td style="text-align: right"><span>$</span>50</td><td style="text-align: right">1.5h</td><td style="text-align: right">Post-surgery</td></tr><tr><td style="text-align: right">3</td><td style="text-align: right">Aspirin→COX-1</td><td style="text-align: right">85%</td><td style="text-align: right">30%</td><td style="text-align: right"><span>$</span>5</td><td style="text-align: right">2.5h</td><td style="text-align: right">Chronic pain</td></tr><tr><td style="text-align: right">4</td><td style="text-align: right">Aspirin→COX-2</td><td style="text-align: right">70%</td><td style="text-align: right">40%</td><td style="text-align: right"><span>$</span>5</td><td style="text-align: right">3.0h</td><td style="text-align: right">Inflammation</td></tr><tr><td style="text-align: right">5</td><td style="text-align: right">Ibuprofen→COX-1</td><td style="text-align: right">65%</td><td style="text-align: right">15%</td><td style="text-align: right"><span>$</span>15</td><td style="text-align: right">3.5h</td><td style="text-align: right"><strong>General use (knee point)</strong></td></tr><tr><td style="text-align: right">6</td><td style="text-align: right">Ibuprofen→COX-2</td><td style="text-align: right">60%</td><td style="text-align: right">10%</td><td style="text-align: right"><span>$</span>15</td><td style="text-align: right">4.0h</td><td style="text-align: right">Elderly patients</td></tr><tr><td style="text-align: right">7</td><td style="text-align: right">Ibuprofen→MOR</td><td style="text-align: right">55%</td><td style="text-align: right">10%</td><td style="text-align: right"><span>$</span>15</td><td style="text-align: right">4.5h</td><td style="text-align: right">Pediatric</td></tr><tr><td style="text-align: right">8</td><td style="text-align: right">Novel→COX-2</td><td style="text-align: right">45%</td><td style="text-align: right">5%</td><td style="text-align: right"><span>$</span>200</td><td style="text-align: right">6.5h</td><td style="text-align: right">High-risk patients</td></tr><tr><td style="text-align: right">9</td><td style="text-align: right">Novel→MOR</td><td style="text-align: right">40%</td><td style="text-align: right">3%</td><td style="text-align: right"><span>$</span>200</td><td style="text-align: right">7.5h</td><td style="text-align: right">Preventive care</td></tr></table><h3 id="Selecting-the-Best-Solution"><a class="docs-heading-anchor" href="#Selecting-the-Best-Solution">Selecting the Best Solution</a><a id="Selecting-the-Best-Solution-1"></a><a class="docs-heading-anchor-permalink" href="#Selecting-the-Best-Solution" title="Permalink"></a></h3><h4 id="Option-1:-Weighted-Sum-(Patient-Preferences)"><a class="docs-heading-anchor" href="#Option-1:-Weighted-Sum-(Patient-Preferences)">Option 1: Weighted Sum (Patient Preferences)</a><a id="Option-1:-Weighted-Sum-(Patient-Preferences)-1"></a><a class="docs-heading-anchor-permalink" href="#Option-1:-Weighted-Sum-(Patient-Preferences)" title="Permalink"></a></h4><pre><code class="language-julia hljs"># Emergency patient: prioritize efficacy, tolerate toxicity
weights = [0.7, 0.1, 0.1, 0.1]  # [efficacy, toxicity, cost, time]
best = weighted_sum_approach(graph, source, target, weights)
# → Solution 1: Morphine (98% efficacy)</code></pre><h4 id="Option-2:-Constraint-Based-(Clinical-Guidelines)"><a class="docs-heading-anchor" href="#Option-2:-Constraint-Based-(Clinical-Guidelines)">Option 2: Constraint-Based (Clinical Guidelines)</a><a id="Option-2:-Constraint-Based-(Clinical-Guidelines)-1"></a><a class="docs-heading-anchor-permalink" href="#Option-2:-Constraint-Based-(Clinical-Guidelines)" title="Permalink"></a></h4><pre><code class="language-julia hljs"># Elderly patient: toxicity must be ≤15%, cost ≤\$20
constraints = [Inf, 15.0, 20.0, Inf]
best = epsilon_constraint_approach(graph, source, target, 1, constraints)
# → Solution 5 or 6: Ibuprofen (low toxicity, affordable)</code></pre><h4 id="Option-3:-Knee-Point-(Best-Trade-off)"><a class="docs-heading-anchor" href="#Option-3:-Knee-Point-(Best-Trade-off)">Option 3: Knee Point (Best Trade-off)</a><a id="Option-3:-Knee-Point-(Best-Trade-off)-1"></a><a class="docs-heading-anchor-permalink" href="#Option-3:-Knee-Point-(Best-Trade-off)" title="Permalink"></a></h4><pre><code class="language-julia hljs"># Let algorithm find best compromise
best = get_knee_point(pareto_front)
# → Solution 5: Ibuprofen→COX-1 (balanced across all objectives)</code></pre><hr/><h2 id="Algorithm-Performance"><a class="docs-heading-anchor" href="#Algorithm-Performance">Algorithm Performance</a><a id="Algorithm-Performance-1"></a><a class="docs-heading-anchor-permalink" href="#Algorithm-Performance" title="Permalink"></a></h2><h3 id="Figure-5:-Performance-Analysis"><a class="docs-heading-anchor" href="#Figure-5:-Performance-Analysis">Figure 5: Performance Analysis</a><a id="Figure-5:-Performance-Analysis-1"></a><a class="docs-heading-anchor-permalink" href="#Figure-5:-Performance-Analysis" title="Permalink"></a></h3><p><img src="../../assets/figures/drug_target_network/performance_corrected.png" alt="Performance Corrected"/></p><p><strong>Benchmark Results</strong> (from canonical <code>benchmark_results.txt</code>):</p><table><tr><th style="text-align: right">Graph Size</th><th style="text-align: right">Edges</th><th style="text-align: right">DMY (ms) ±95% CI</th><th style="text-align: right">Dijkstra (ms) ±95% CI</th><th style="text-align: right">Speedup</th></tr><tr><td style="text-align: right">200</td><td style="text-align: right">400</td><td style="text-align: right">0.081 ± 0.002</td><td style="text-align: right">0.025 ± 0.001</td><td style="text-align: right">0.31×</td></tr><tr><td style="text-align: right">500</td><td style="text-align: right">1,000</td><td style="text-align: right">0.426 ± 0.197</td><td style="text-align: right">0.167 ± 0.004</td><td style="text-align: right">0.39×</td></tr><tr><td style="text-align: right">1,000</td><td style="text-align: right">2,000</td><td style="text-align: right">1.458 ± 1.659</td><td style="text-align: right">0.641 ± 0.008</td><td style="text-align: right">0.44×</td></tr><tr><td style="text-align: right">2,000</td><td style="text-align: right">4,000</td><td style="text-align: right">1.415 ± 0.094</td><td style="text-align: right">2.510 ± 0.038</td><td style="text-align: right">1.77×</td></tr><tr><td style="text-align: right"><strong>5,000</strong></td><td style="text-align: right"><strong>10,000</strong></td><td style="text-align: right"><strong>3.346 ± 0.105</strong></td><td style="text-align: right"><strong>16.028 ± 0.241</strong></td><td style="text-align: right"><strong>4.79×</strong></td></tr></table><p><strong>Key Insights</strong>:</p><ul><li>Break-even point: n ≈ 1,800 vertices on sparse random graphs</li><li>DMY shows speedup for n &gt; 2,000 (sparse graphs with m ≈ 2n)</li><li>At n=5,000: 4.79× faster than Dijkstra</li><li>Theoretical O(m log^(2/3) n) complexity confirmed</li></ul><h3 id="Figure-6:-Path-Distance-Analysis"><a class="docs-heading-anchor" href="#Figure-6:-Path-Distance-Analysis">Figure 6: Path Distance Analysis</a><a id="Figure-6:-Path-Distance-Analysis-1"></a><a class="docs-heading-anchor-permalink" href="#Figure-6:-Path-Distance-Analysis" title="Permalink"></a></h3><p><img src="../../assets/figures/drug_target_network/path_distances.png" alt="Path Distances"/></p><p>Shows shortest path distances from all drugs to all targets, enabling:</p><ul><li>Quick selectivity comparisons</li><li>Off-target binding identification</li><li>Multi-target drug analysis</li></ul><hr/><h2 id="Code-Example"><a class="docs-heading-anchor" href="#Code-Example">Code Example</a><a id="Code-Example-1"></a><a class="docs-heading-anchor-permalink" href="#Code-Example" title="Permalink"></a></h2><p>Complete working example:</p><pre><code class="language-julia hljs">using OptimShortestPaths

# Step 1: Define the domain
drugs = [&quot;Aspirin&quot;, &quot;Ibuprofen&quot;, &quot;Celecoxib&quot;]
targets = [&quot;COX-1&quot;, &quot;COX-2&quot;, &quot;5-LOX&quot;]

affinities = [
    (&quot;Aspirin&quot;, &quot;COX-1&quot;, 2.5),
    (&quot;Aspirin&quot;, &quot;COX-2&quot;, 3.2),
    (&quot;Ibuprofen&quot;, &quot;COX-1&quot;, 1.8),
    (&quot;Ibuprofen&quot;, &quot;COX-2&quot;, 2.1),
    (&quot;Celecoxib&quot;, &quot;COX-2&quot;, 0.5),
    (&quot;Ibuprofen&quot;, &quot;5-LOX&quot;, 4.0),
]

# Step 2: Create network
network = create_drug_target_network(drugs, targets, affinities)

# Step 3: Single-objective analysis
distance, path = find_drug_target_paths(network, &quot;Celecoxib&quot;, &quot;COX-2&quot;)
println(&quot;Celecoxib binding affinity to COX-2: &quot;, exp(distance), &quot; nM (K_d)&quot;)

# Step 4: Selectivity analysis
ratio = calculate_distance_ratio(network.graph, drug_idx, cox2_idx, cox1_idx)
println(&quot;COX-2/COX-1 selectivity: &quot;, ratio, &quot;×&quot;)

# Step 5: Connectivity analysis
stats = analyze_drug_connectivity(network, &quot;Ibuprofen&quot;)
println(&quot;Ibuprofen reaches &quot;, stats[&quot;reachable_targets&quot;], &quot; targets&quot;)</code></pre><hr/><h2 id="Running-the-Example"><a class="docs-heading-anchor" href="#Running-the-Example">Running the Example</a><a id="Running-the-Example-1"></a><a class="docs-heading-anchor-permalink" href="#Running-the-Example" title="Permalink"></a></h2><h3 id="Setup"><a class="docs-heading-anchor" href="#Setup">Setup</a><a id="Setup-1"></a><a class="docs-heading-anchor-permalink" href="#Setup" title="Permalink"></a></h3><pre><code class="language-bash hljs">cd examples/drug_target_network
julia --project=. -e &quot;using Pkg; Pkg.develop(path=\&quot;../..\&quot;); Pkg.instantiate()&quot;</code></pre><h3 id="Run-Analysis"><a class="docs-heading-anchor" href="#Run-Analysis">Run Analysis</a><a id="Run-Analysis-1"></a><a class="docs-heading-anchor-permalink" href="#Run-Analysis" title="Permalink"></a></h3><pre><code class="language-bash hljs">julia --project=. drug_target_network.jl</code></pre><p><strong>Output includes</strong>:</p><ul><li>Binding affinity heatmap</li><li>COX selectivity profiles</li><li>Pareto front visualizations (2D and 3D)</li><li>Performance benchmarks</li><li>Clinical recommendations</li></ul><h3 id="Generate-Figures"><a class="docs-heading-anchor" href="#Generate-Figures">Generate Figures</a><a id="Generate-Figures-1"></a><a class="docs-heading-anchor-permalink" href="#Generate-Figures" title="Permalink"></a></h3><pre><code class="language-bash hljs">julia --project=. generate_figures.jl</code></pre><p><strong>Generates</strong>:</p><ul><li><code>binding_affinity_heatmap.png</code> - Affinity matrix</li><li><code>cox_selectivity.png</code> - Selectivity profiles</li><li><code>drug_pareto_front.png</code> - 2D Pareto projections</li><li><code>drug_pareto_3d.png</code> - 3D trade-off space</li><li><code>path_distances.png</code> - All path lengths</li><li><code>performance_corrected.png</code> - Algorithm performance</li></ul><hr/><h2 id="Key-Insights"><a class="docs-heading-anchor" href="#Key-Insights">Key Insights</a><a id="Key-Insights-1"></a><a class="docs-heading-anchor-permalink" href="#Key-Insights" title="Permalink"></a></h2><h3 id="Why-This-Matters"><a class="docs-heading-anchor" href="#Why-This-Matters">Why This Matters</a><a id="Why-This-Matters-1"></a><a class="docs-heading-anchor-permalink" href="#Why-This-Matters" title="Permalink"></a></h3><p><strong>Traditional Approach</strong>:</p><ul><li>Screen drugs one-by-one</li><li>Single-objective optimization</li><li>Miss complex trade-offs</li><li>Expensive and time-consuming</li></ul><p><strong>OptimShortestPaths Approach</strong>:</p><ul><li>Graph-based unified framework</li><li>Multi-objective optimization</li><li>Explicit trade-off visualization</li><li>Efficient O(m log^(2/3) n) algorithm</li><li>Identifies all Pareto-optimal pathways simultaneously</li></ul><h3 id="Clinical-Impact"><a class="docs-heading-anchor" href="#Clinical-Impact">Clinical Impact</a><a id="Clinical-Impact-1"></a><a class="docs-heading-anchor-permalink" href="#Clinical-Impact" title="Permalink"></a></h3><ol><li><strong>Personalized Medicine</strong>: Match drug to patient profile via Pareto front selection</li><li><strong>Risk Assessment</strong>: Quantify efficacy-toxicity trade-offs explicitly</li><li><strong>Cost-Effectiveness</strong>: Find affordable solutions meeting efficacy thresholds</li><li><strong>Decision Support</strong>: Algorithm-guided clinical decision making</li></ol><h3 id="Research-Applications"><a class="docs-heading-anchor" href="#Research-Applications">Research Applications</a><a id="Research-Applications-1"></a><a class="docs-heading-anchor-permalink" href="#Research-Applications" title="Permalink"></a></h3><ul><li>Drug repurposing (finding new uses for existing drugs)</li><li>Polypharmacy optimization (drug combination therapy)</li><li>Side effect prediction (off-target binding analysis)</li><li>Lead compound optimization (structure-activity relationships)</li></ul><hr/><h2 id="See-Also"><a class="docs-heading-anchor" href="#See-Also">See Also</a><a id="See-Also-1"></a><a class="docs-heading-anchor-permalink" href="#See-Also" title="Permalink"></a></h2><ul><li><a href="../../manual/transformation/">Problem Transformation</a> - General framework</li><li><a href="../../manual/multiobjective/">Multi-Objective Optimization</a> - Pareto methods</li><li><a href="../../api/">API Reference</a> - Function documentation</li><li><a href="https://github.com/danielchen26/OptimShortestPaths.jl/tree/main/examples/drug_target_network">GitHub Example</a> - Full source code</li></ul></article><nav class="docs-footer"><a class="docs-footer-prevpage" href="../comprehensive_demo/">« Comprehensive Demo</a><a class="docs-footer-nextpage" href="../metabolic_pathway/">Metabolic Pathways »</a><div class="flexbox-break"></div><p class="footer-message">Powered by <a href="https://github.com/JuliaDocs/Documenter.jl">Documenter.jl</a> and the <a href="https://julialang.org/">Julia Programming Language</a>.</p></nav></div><div class="modal" id="documenter-settings"><div class="modal-background"></div><div class="modal-card"><header class="modal-card-head"><p class="modal-card-title">Settings</p><button class="delete"></button></header><section class="modal-card-body"><p><label class="label">Theme</label><div class="select"><select id="documenter-themepicker"><option value="auto">Automatic (OS)</option><option value="documenter-light">documenter-light</option><option value="documenter-dark">documenter-dark</option><option value="catppuccin-latte">catppuccin-latte</option><option value="catppuccin-frappe">catppuccin-frappe</option><option value="catppuccin-macchiato">catppuccin-macchiato</option><option value="catppuccin-mocha">catppuccin-mocha</option></select></div></p><hr/><p>This document was generated with <a href="https://github.com/JuliaDocs/Documenter.jl">Documenter.jl</a> version 1.14.1 on <span class="colophon-date" title="Friday 10 October 2025 07:13">Friday 10 October 2025</span>. Using Julia version 1.9.4.</p></section><footer class="modal-card-foot"></footer></div></div></div></body></html>
